SCHEMBL7905681

SCHEMBL7905681

COc1ccc(CC(=O)NC(C)=O)cc1

nearest known ligand 0.71

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 0.71
▸ ALDH1A1 P00352 3/20 0.59
▸ MAPT P10636 2/20 0.59
▸ MEN1 O00255 1/20 0.59
▸ KMT2A Q03164 1/20 0.59
▸ SMN1; SMN2 Q16637 3/20 0.58
▸ NPC1 O15118 1/20 0.58
▸ LMNA P02545 1/20 0.58
▸ TDP1 Q9NUW8 1/20 0.56
▸ EPHX2 P34913 1/20 0.56
▸ MAPK1 P28482 1/20 0.56
▸ RAB9A P51151 2/20 0.55
▸ KLK7 P49862 1/20 0.55
▸ CNR2 P34972 2/20 0.54
▸ ERCC1 P07992 1/20 0.54
▸ ERCC4 Q92889 1/20 0.54
▸ EGFR P00533 1/20 0.54
▸ ERBB2 P04626 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16661792 0.83 HTT (0.63) HTTALDH1A1MAPTMEN1KMT2A
SCHEMBL23336142 0.83 HTT (0.57) HTTALDH1A1MAPTMEN1KMT2A
SCHEMBL7916079 0.83 SMN1; SMN2 (0.57) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL30986878 0.83 ALDH1A1 (0.65) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL7919541 0.82 KDM4E (0.54) HTTALDH1A1MAPTMEN1KMT2A
SCHEMBL3369060 0.81 HTT (0.76) HTTALDH1A1MAPTMEN1KMT2A
SCHEMBL10684986 0.81 HTT (0.76) HTTALDH1A1MAPTMEN1KMT2A
SCHEMBL17993501 0.81 HTT (0.65) HTTALDH1A1MAPTMEN1KMT2A
SCHEMBL4162497 0.81 HTT (0.65) HTTALDH1A1MAPTMEN1KMT2A
SCHEMBL169824 0.80 TDP1 (0.76) HTTALDH1A1MEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010048340-A2 NOVEL SEMI-SYNTHETIC GLYCOPEPTIDES AS ANTIBACTERIAL AGENTS LEAD THERAPEUTICS, INC. (US) 2010-04-29 — — WO disclosed
Send feedback